Formulations of multilamellar liposomes containing a metabolite of arachidonic acid.

The invention provides a liposome MUTILAMELAR CONTAINING arachidonic acid metabolite two or more lipid bilayers containing TWO or more aqueous compartments containing a neutralizer release inhibitor. Metabolites arachidonic acid Preferred Prostaglandins, particularly PGE1. FORMULATIONS liposomal be used to treat animals, particularly humans, diseases, disorders or conditions which may be improved by Prostaglandin, FOR EXAMPLE, diseases characterized by ACTIVATION AND CELL ADHESION, inflammation and / or toxemia.